 NEW YORK, April 20, 2021 PRNewswire -- Empire State Realty Trust, Inc. NYSE: ESRT announced today that Zentalis Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics that target fundamental biological pathways of cancers, has signed a new lease with ESRT for a 31,362 square foot office space at 1359 Broadway. At Zentalis, we are committed to ensuring our employees safety and wellbeing, and we are thrilled our new corporate office space will provide our growing team with a healthy and productive work environment to help bring innovative cancer treatments to patients, commented Dr. Anthony Sun, chairman and chief executive officer of Zentalis Pharmaceuticals. 